Monogram Technologies Inc., an AI-driven robotics company specializing in orthopedic surgery, announced the mandatory conversion of its 8.00% Series D Convertible Cumulative Preferred Stock. This decision comes after the company's common stock maintained a closing price of at least $2.8125 per share for ten consecutive trading days, triggering the conversion as per the terms outlined in the Certificate of Designation. The conversion will take effect on July 14, 2025, impacting all outstanding shares issued during the company's October 1, 2024 offering. This strategic move is part of Monogram's ongoing efforts to streamline its capital structure and enhance shareholder value.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。